These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke? Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI. J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555 [Abstract] [Full Text] [Related]
6. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study. Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC. J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101 [Abstract] [Full Text] [Related]
15. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke. Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D. Cerebrovasc Dis; 2013 Nov; 35(1):45-52. PubMed ID: 23428996 [Abstract] [Full Text] [Related]